These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24973521)

  • 1. Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells.
    Qian Y; Wang X; Liu Y; Li Y; Colvin RA; Tong L; Wu S; Chen X
    Cancer Lett; 2014 Sep; 351(2):242-51. PubMed ID: 24973521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular ATP a New Player in Cancer Metabolism: NSCLC Cells Internalize ATP In Vitro and In Vivo Using Multiple Endocytic Mechanisms.
    Qian Y; Wang X; Li Y; Cao Y; Chen X
    Mol Cancer Res; 2016 Nov; 14(11):1087-1096. PubMed ID: 27578770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase.
    Wang X; Li Y; Qian Y; Cao Y; Shriwas P; Zhang H; Chen X
    Oncotarget; 2017 Oct; 8(50):87860-87877. PubMed ID: 29152126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents.
    Steiner L; Blum G; Friedmann Y; Levitzki A
    Eur J Pharmacol; 2007 May; 562(1-2):1-11. PubMed ID: 17376430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenine nucleotides inhibit proliferation of the human lung adenocarcinoma cell line LXF-289 by activation of nuclear factor kappaB1 and mitogen-activated protein kinase pathways.
    Schäfer R; Hartig R; Sedehizade F; Welte T; Reiser G
    FEBS J; 2006 Aug; 273(16):3756-67. PubMed ID: 16911524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM; Saigal B; Talpaz M; Donato NJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular ATP and UTP activate the protein kinase B/Akt cascade via the P2Y(2) purinoceptor in renal mesangial cells.
    Huwiler A; Rölz W; Dorsch S; Ren S; Pfeilschifter J
    Br J Pharmacol; 2002 Jun; 136(4):520-9. PubMed ID: 12055130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
    Song J; Ko HS; Sohn EJ; Kim B; Kim JH; Kim HJ; Kim C; Kim JE; Kim SH
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1188-91. PubMed ID: 24461294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular and macropinocytosis internalized ATP work together to induce epithelial-mesenchymal transition and other early metastatic activities in lung cancer.
    Cao Y; Wang X; Li Y; Evers M; Zhang H; Chen X
    Cancer Cell Int; 2019; 19():254. PubMed ID: 31582910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
    Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
    Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice.
    Nielsen CM; Qian Y; Adhicary S; Li Y; Shriwas P; Wang X; Bachmann L; Chen X
    J Vis Exp; 2021 Jun; (172):. PubMed ID: 34279488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells.
    Hirata A; Hosoi F; Miyagawa M; Ueda S; Naito S; Fujii T; Kuwano M; Ono M
    Cancer Res; 2005 May; 65(10):4253-60. PubMed ID: 15899817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.
    Xie M; He CS; Wei SH; Zhang L
    Eur J Cancer; 2013 Nov; 49(16):3559-72. PubMed ID: 23916913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
    Knouzy B; Dubourg L; Baverel G; Michoudet C
    J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis-related molecular differences for response to tyrosin kinase inhibitors in drug-sensitive and drug-resistant human bladder cancer cells.
    Li J; Lv B; Li X; He Z; Zhou K
    J Cancer Res Ther; 2013; 9(4):668-71. PubMed ID: 24518715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition.
    Nakachi I; Naoki K; Soejima K; Kawada I; Watanabe H; Yasuda H; Nakayama S; Yoda S; Satomi R; Ikemura S; Terai H; Sato T; Ishizaka A
    Mol Cancer Res; 2010 Aug; 8(8):1142-51. PubMed ID: 20647329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
    Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.
    Xu RH; Pelicano H; Zhou Y; Carew JS; Feng L; Bhalla KN; Keating MJ; Huang P
    Cancer Res; 2005 Jan; 65(2):613-21. PubMed ID: 15695406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.